Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD). For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).
|08/14/08||10-Q||Quarterly report pursuant to sections 13 or 15(d)||13|
|05/15/08||10-Q||Quarterly report pursuant to sections 13 or 15(d)||13|
|04/18/08||EFFECT||Notice of Effectiveness||1|
|04/09/08||S-1||General form of registration statement for all companies including face-amount certificate companies||64|